HAVN Life Sciences Inc.

CSE: HAVN, 5NP.F

Company Logo

Company Overview

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. 

Financial Highlights

$9,367

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.39

Diluted EPS (ttm)

Management Team

Mr. Tim Moore
CEO & Director

Mr. Gordon Clissold FCGA, FCPA
Chief Financial Officer

Ms. Jenna Pozar
Chief Operating Officer

Mr. Gary Joseph Leong
Chief Science Officer

Dr. Ivan Casselman
Chief Psychedelics Officer

Mr. Alexzander Samuelsson
Chief Research Officer

Mr. Paul More
Controller

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$11,790,515

Shares Outstanding
66,771,000

Shares Short (% of Float)
()

Insider Ownership
1%